Literature DB >> 8822354

Prediction of perimenopausal fractures by bone mineral density and other risk factors.

D J Torgerson1, M K Campbell, R E Thomas, D M Reid.   

Abstract

In a prospective population-based cohort study, we assessed whether bone mineral density (BMD) measurements of perimenopausal women and other risk factors for osteoporosis are predictive of subsequent fracture. Women aged 47-51 years chosen randomly from a population register who underwent a bone density measurement 2 years previously were followed up by questionnaire to assess the 2-year incidence of any self-reported fractures. We found that 44 women, out of 1857 who completed the questionnaire, sustained at least one fracture within a 2-year follow-up period. After adjustment for covariates, the odds ratio of sustaining a fracture was 1.6 (95% confidence interval [CI] 1.16-2.34) for every standard deviation reduction in BMD at the spine, for women with a prior history of fracture the odds ratio of a subsequent fracture was approximately 2 (95% CI 1.31-3.03), a family history of hip fracture (maternal grandmother) carried an odds ratio of 3.7 (95% CI 1.55-8.85), while being postmenopausal or having a hysterectomy resulted in an odds ratio of 1.98 (1.02-3.56). This study has shown that BMD measurements at the hip and spine and other risk factors predict any nonhip and nonspine perimenopausal fractures. Further follow-up is required to assess the predictive performance of BMD measurements and other risk factors for hip and spine fractures.

Entities:  

Mesh:

Year:  1996        PMID: 8822354     DOI: 10.1002/jbmr.5650110219

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  24 in total

Review 1.  Genetics of osteoporosis.

Authors:  Huilin Jin; Stuart H Ralston
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

2.  Risk of new clinical fractures within 2 years following a fracture.

Authors:  Svenhjalmar van Helden; Jochen Cals; Fons Kessels; Peter Brink; Geert Jan Dinant; Piet Geusens
Journal:  Osteoporos Int       Date:  2005-12-24       Impact factor: 4.507

3.  Influence of hysterectomy on long-term fracture risk.

Authors:  L Joseph Melton; Sara J Achenbach; John B Gebhart; Ebenezer O Babalola; Elizabeth J Atkinson; Adil E Bharucha
Journal:  Fertil Steril       Date:  2007-01-30       Impact factor: 7.329

Review 4.  Unveiling the mysteries of the genetics of osteoporosis.

Authors:  N Alonso; S H Ralston
Journal:  J Endocrinol Invest       Date:  2014-08-23       Impact factor: 4.256

5.  The pharmacoeconomics of hormone replacement therapy.

Authors:  D J Torgerson; D M Reid
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

6.  Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone.

Authors:  O M E Albagha; U Pettersson; A Stewart; F E A McGuigan; H M MacDonald; D M Reid; S H Ralston
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

7.  Evaluation and management of osteoporosis following hospitalization for low-impact fracture.

Authors:  Christine Simonelli; Ya-Ting Chen; Julie Morancey; Anne F Lewis; Thomas A Abbott
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

8.  Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; X Sherry Liu; Emily M Stein; Donald J McMahon; Halley F Rogers; Jeanette Lemaster; Robert R Recker; Joan M Lappe; X Edward Guo; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

Review 9.  Comparing non-vertebral fracture risk reduction with osteoporosis therapies: looking beneath the surface.

Authors:  A Sebba
Journal:  Osteoporos Int       Date:  2008-12-04       Impact factor: 4.507

10.  Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women.

Authors:  J Huopio; H Kröger; R Honkanen; J Jurvelin; S Saarikoski; E Alhava
Journal:  Osteoporos Int       Date:  2004-01-16       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.